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ABSTRACT
An internal ribosomal entry site (IRES) that directs
the initiation of viral protein translation is a potential
drug target for enterovirus 71 (EV71). Regulation of
internal initiation requires the interaction of IRES
trans-acting factors (ITAFs) with the internal riboso-
mal entry site. Biotinylated RNA-affinity chromato-
graphy and proteomic approaches were employed
to identify far upstream element (FUSE) binding pro-
tein 2 (FBP2) as an ITAF for EV71. The interactions of
FBP2 with EV71 IRES were confirmed by competi-
tion assay and by mapping the association sites in
both viral IRES and FBP2 protein. During EV71 infec-
tion, FBP2 was enriched in cytoplasm where viral
replication occurs, whereas FBP2 was localized in
the nucleus in mock-infected cells. The synthesis of
viral proteins increased in FBP2-knockdown cells
that were infected by EV71. IRES activity in FBP2-
knockdown cells exceeded that in the negative con-
trol (NC) siRNA-treated cells. On the other hand,
IRES activity decreased when FBP2 was over-
expressed in the cells. Results of this study suggest
that FBP2 is a novel ITAF that interacts with EV71
IRES and negatively regulates viral translation.
INTRODUCTION
Enterovirus 71 (EV71), a positive-stranded RNA virus of
the Picornaviridae family, poses a persistent global public
health problem. EV71 presents most frequently as a child
herpangina or exanthema, known as hand, foot and
mouth disease (HFMD). However, acute EV71 infection
is also associated with severe neurological complications
with signiﬁcant mortality. Children under 5-year-old are
particularly susceptible to the most severe forms of EV71-
associated neurological complications, including aseptic
meningitis, brainstem and/or cerebellar encephalitis, myo-
carditis, acute ﬂaccid paralysis and rapid fatal pulmonary
edema and hemorrhage (1). Such presentations as well as a
poliomyelitis-like syndrome have been observed during
outbreaks in Taiwan, mainland China, Malaysia,
Singapore, western Australia, the United States and
Europe (2–8). With the emergence of EV71 worldwide as
the major causative agent of HFMD fatalities in recent
years, and in the absence of any eﬀective anti-enteroviral
therapy, a need clearly exists to ﬁnd a speciﬁc anti-EV71
agent. The internal ribosomal entry site (IRES) of EV71 is
a good target for the development of an antiviral agent
because viral replication can be restricted by inhibiting
IRES-mediated viral translation.
A 40S ribosomal subunit recognizes a sequence, RNA
structure or ribonucleoprotein complex within the IRES,
and initiation occurs at the authentic start codon of the
picornaviral RNA. During infection by poliovirus (PV),
human rhinovirus (HRV), EV71 or coxsackievirus, the
viral proteases 3C and 2A cleave cellular proteins, includ-
ing the translation initiation factor eIF4G, causing rapid
termination of the host cap-dependent translation (9–12).
The IRES-mediated initiation of translation allows viral
RNA translation while host cell translation is shut down
during infection. IRES-dependent translation depends on
both canonical translation initiation factors and IRES-
speciﬁc trans-acting factors (ITAFs). These ITAFs inter-
act with various IRES elements to regulate their activities
by aﬀecting ribosome recruitment or modifying the struc-
ture of the IRES itself. Several proteins that modulate the
picornaviral IRES function as ITAFs have been identiﬁed:
these include polypyrimidine tract binding protein (PTB),
poly(rC)-binding protein 1 (PCBP1), poly(rC)-binding
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tein (Unr) and ITAF45 (13–16).
Only a few investigations have described the IRES for
EV71 (12,17), and the ITAFs for EV71 have not been
intensively studied. This work reports the use of the bio-
tinylated RNA-protein pull-down approach followed by
matrix-assisted laser desorption ionization/time-of-light
mass spectrometer (MALDI-TOF) analysis, to identify
12 cellular proteins that are associated with EV71 50
UTR which contains IRES in SF268 cells. Three of
these—PTB, PCBP1 and PCBP2—shown have already
been demonstrated to interact with the 50 UTR of picor-
navirus (18–20). This investigation identiﬁes FBP2 as one
of the cellular proteins that is associated with the EV71 50
UTR in vitro and in vivo. The interaction between FBP2
and EV71 50 UTR was further conﬁrmed by mapping the
interaction regions in both viral RNA and FBP2 protein.
The localization of FBP2 in EV71 infected-cells was exam-
ined and the role of FBP2 in viral translation was also
investigated.
MATERIALS AND METHODS
Plasmid construction
The pT7-EV71 50 UTR was constructed as follows: the
50 UTR of EV71 was ampliﬁed by PCR from the EV71
full-length infectious cDNA clone (21) using EV71
50-(GCCGGTAATACGACTCACTATAGGGAGATTA
AAACAGCCTGTGGGT) and EV71 50-(CATGTTTGA
TTGTGTTGAGGGTCAAAAT) primers that contained
the T7 promoter, and was cloned into pCRII-TOPO
vector by TA cloning (Invitrogen, California, USA).
pCMV-tag2B-KSRP (a gift from Dr. Roberto Gherzi,
Istituto Nazionale per la Ricerca sul Cancro, Italy) was
utilized to construct various truncated forms of ﬂag-
tagged KH motifs of FBP2, and fragments were ampliﬁed
by PCR using a 50 primer that contained an EcoR I site
a n da3 0 primer that contained a Xho I site. PCR products
were subcloned between the EcoR I and Xho I sites of
pCMV-tag2B vector.
The pRHF was constructed as follows: Renilla Lucifer-
ase gene (R) was inserted in EcoR I site of pTriEx-4;
Fireﬂy Luciferase gene (F) was inserted in Xho I of
pTriEx-4; A hairpin (H) was inserted downstream of the
Renilla Luciferase gene to prevent ribosome read-through.
A dicistronic reporter plasmid, pRHF–EV71-50 UTR,
containing EV71 50 UTR between Renilla and Fireﬂy
luciferase was constructed by insert a Not I–EV71-50
UTR–Not I fragment to pRHF.
Preparation ofSK-N-MC, SF268and RD cell extracts
SK-N-MC (human neuroblastoma), SF268 (human glio-
blastoma) and RD (human embryonal rhabdomyosar-
coma) cells were grown in Dulbecco’s Modiﬁed Eagle
medium (GIBCO, California, USA) supplemented with
10% fetal bovine serum. Upon conﬂuence, cells were pel-
leted, washed three times with cold PBS, resuspended in
CHAPS buﬀer (10mM Tris–HCl pH 7.4, 1mM MgCl2,
1mM EGTA, 0.5% CHAPS, 10% glycerol, 0.1mM
PMSF, 5mM 2-ME), and then incubated on ice for
30min for swelling. Cell lysates were isolated by centrifu-
gation at 10 000g for 10min at 48C, and the supernatants
were collected for further analysis. The concentrations of
the proteins in the cell extracts were determined using the
Bio-Rad protein assay (Bio-Rad, Hercules, CA).
In vitro transcription
The T7 promoter–EV71-50 UTR fragment that was
ﬂanked by EcoR I sites was excised from the pCRII-
TOPO vector. RNA transcripts were synthesized using
the MEGAscript T7 kit (Ambion, Texas, USA), according
to the protocol provided by the manufacturer. Biotinyl-
ated RNA was synthesized in a 20ml MEGAscript tran-
scription reaction mixture by the addition of 1.25mlo f
20mM biotinylated UTP, Bio-16-UTP, which is a sub-
strate for SP6, T3 and T7 RNA polymerases and can
replace UTP in the in vitro transcription for RNA labeling
(Roche, Penzberg, Germany). Synthesized RNAs were
puriﬁed using the RNeasy Protect Mini Kit (Nobel,
Hilden, Germany) and analyzed on 1% agarose gels.
Isolation of proteins associated withEV715’ UTR RNA
sequences by affinitybinding to biotinylated RNA
A reaction mixture that contained 200mg of cell extracts
and 12.5 pmol of a biotinylated EV71 50 UTR RNA probe
was made. The mixture (with a ﬁnal volume of 100ml),
which contained 5mM HEPES pH 7.1, 40mM KCl,
0.1mM EDTA, 2mM MgCl2, 2mM dithiothreitol,
1 unit RNasin and 0.25mg/ml heparin (RNA mobility
shift buﬀer), was incubated for 15min at 308C, and
then added to 400ml of Streptavidin MagneSphere
Paramagnetic Particles (Promega, Wisconsin, USA) for
binding for 10min at room temperature. The protein–
RNA complexes were washed ﬁve times with the RNA
mobility shift buﬀer without heparin. After the last
wash, 30mlo f2  SDS–PAGE sample buﬀer was added
to the beads, which were then incubated for 10min at
room temperature to dissociate the proteins from the
RNA. The sample that contained the eluted proteins
was then boiled, subjected to 8–16% SDS–PAGE, and
further visualized by silver staining or western blotting.
Proteins bands were excised and identiﬁed by in-gel tryp-
sin digestion and analyzed by Bruker Ultraﬂex MALDI-
TOF mass spectrometry.
Database-searching algorithm
After the masses that were derived from the standards,
trypsin, matrix and keratins had been removed, the mono-
isotopic mass lists for each protonated peptide were used
to search the database. Mass lists were exported to the
Biotool 2.0 software package to perform peptide mass
ﬁngerprinting via Mascot (http://www.matrixscience.com)
algorithm scoring to identify proteins.
Western blot analysis
PVDF membranes were blocked with Tris-buﬀered saline/
0.1% (vol/vol) Tween 20 that contained 5% non-fat dry
milk and probed with the indicated antibodies. The anti-
bodies against FBP2 (1:200; Santa Cruz Biotechnology,
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Biotechnology, Santa Cruz, CA, USA), ﬂag (1:2000;
SIGMA, Missouri, USA) and actin (1:5000; Chemicon,
USA) were used. After washing, the membrane was incu-
bated with HRP-conjugated anti-mouse antibody or
HRP-congugated anti-goat antibody, as appropriate
(diluted 1:5000). HRP was detected using the Western
Lightning Chemiluminescence Kit, following the manu-
facturer’s protocol (Amersham Pharmacia, Freiburg,
Germany).
Coimmunoprecipitation and RT-PCR
Cell extracts from EV71-infected RD cells for use in coim-
munoprecipitation assays were prepared at 6h post-
infection. Lysates were precleared by incubation on ice
for 1h with protein A-agarose (50% in lysis buﬀer) that
was bound to non-speciﬁc antibody. Non-speciﬁc com-
plexes were pelleted by centrifugation at 10000g at 48C
for 10min. The supernatants were removed and used in
the immunoprecipitation assay. Next, 100ml of precleared
lysate was diluted with 450ml of lysis buﬀer and then
added to 15ml of ﬂag antibody, before incubation on ice
for 2h. Prewashed protein A-agarose [100ml in PBS
(50:50)] was added to each sample, which was then incu-
bated on ice for an additional hour. Immune complexes
were pelleted by centrifugation at 1000g at 48C for 5min
and washed three times with lysis buﬀer. Each pellet [or
100ml of precleared lysate (total RNA)] was resuspended
in 400ml of proteinase K buﬀer [100mM Tris–HCl (pH
7.5), 12.5mM EDTA, 150mM NaCl, 1% SDS] and incu-
bated with 100 mg of predigested proteinase K for 30min
at 378C. RNA was extracted with phenol-chloroform, pre-
cipitated in ethanol at –208C for 1h, washed in 70% etha-
nol, dried and resuspended in 20ml DEPC H2O. RT-PCR
was performed using a Reverse-iT One-Step TR-PCR kit
(ABgene, Surry, UK) and either primers speciﬁc to EV71
50 UTR or primers speciﬁc to ribosomal protein S16
(GCGCGGTGAGGTTGTCTAGTC and GAGTTTTG
AGTCACGATGGGC).
Fluorescence microscopic analysis
RD cells grown on glass cover slips were infected with
EV71 for 1h at an MOI of 40. After 6h post-infection,
the culture medium was removed, and the cells washed
three times with PBS. The cells on the coverslip were
ﬁxed with 3.7% (wt/vol.) formaldehyde at room tempera-
ture for 20min. After being washed three times with PBS,
the cells on the coverslip were permeabilized in 0.5%
Triton X-100at room temperature for 5min and washed
again three times with PBS. For ﬂag and EV71 3A immu-
nostaining, the samples were blocked in solution [PBS,
containing 5% bovine serum albumin (BSA)] for 60min
at room temperature and then incubated with anti-ﬂag
antibody (1:200) for 1.5h at room temperature and
washed three times with PBS. The samples were then
reacted with FITC (Fluorescein Isothiocyanate)-
conjugated goat anti-mouse IgG and rhodamine [tetra-
methyl rhodamine isothiocyanate (TRITC)]-conjugated
goat anti-rabbit IgG (Jackson ImmunoResearch Labora-
tories, Inc.) for 1h at room temperature. After being
washed with PBS, the samples were treated with Hoechst
33258 for 15min at room temperature and washed again
with PBS three times. Finally, the coverslips with adhering
cells were placed on a glass slide and sealed with transpar-
ent nail polish. The images were captured by confocal
laser scanning microscopy (ZEISS LSM510 META).
Virus infections andmetabolic radiolabeling
Forty-eight hours after siRNA transfection, 2 10
5 RD
cells were seeded into 12-well plates and incubated at 378C
for 24h. The cells were then infected with EV71at a multi-
plicity of infection of 40 PFU per cell. Virus was adsorbed
at room temperature for 1h. The medium was then
replaced with methionine-free DMEM, and incubation
was continued at 358C. At various times post-infection,
the medium was replaced with medium with
35S-Met label-
ing (50 mCi/ml). After 1h of labeling, the cell monolayers
were washed with PBS and lysed with lysis buﬀer. Cell
lysates were isolated by centrifugation at 10000g for
10min at 48C, and the supernatants were collected for
further analysis. Radiolabeled proteins were resolved by
SDS–PAGE (12% gels), transferred to a PVDF mem-
brane, and detected by autoradiography. The same mem-
brane was used for Western blotting. The sequence of
FBP2 siRNA is 50-CACAUUCGUAUUCUGAGAUCC
GUCC-30 (Invitrogen, KHSRP-HSS112554); and the
sequence of NC siRNA is 50-AACUGGGUAAGCGGG
CGCAAAUU-30.
Dicistronic ormonocistronic expression assay
For dicistronic expression assay, RD cells were ﬁrstly
transfected with either FBP2 siRNA or pFBP2/FLAG.
After 3 days, dicistronic construct pRHF or pRHF–
EV71-50UTR and siRNA duplexes were cotransfected
into RD cells with siRNA duplex. After 2 days, cell
extracts were prepared in passive buﬀer (Promega) and
assayed for Renilla luciferase (RLuc) and Fireﬂy luciferase
(FLuc) activity in a Lumat LB9507 bioluminometer using
a dual-luciferase reporter assay (Promega) according to
the manufacturer’s instructions. For western blotting
experiment, cell lysates were incubated at 958C for
5min, and an equal amount of proteins was resolved on
sodium dodecyl sulfate (SDS)–12% polyacrylamide gels.
For capped dicistronic mRNA containing a poly(A) tail
reporter or monocistronic RNA reporter assay, RD cells
transfected with either FBP2 siRNA or FBP2/FLAG were
grown for 3 days and then transfected with RNA. After
6-h post-transfection, cells were harvested, lysed and
western blotted for FBP2, FBP2/FLAG and actin.
Evaluating RNA replication byslot blotting
RD cells were transfected with FBP2 and NC (negative
control) siRNA for 48h, and then trypsinzed and counted.
About 2 10
5 cells were seeded into 12-well plates. After
24h, the cells were then challenged with EV71 (4643/TW/
1998) at a multiplicity of infection (MOI) of 40 per cell
and were harvested at 1, 2, 3, 4, 5, 6, 7, 8 and 9h post-
infection. RNA were extracted and dissolved in a solution
of formaldehyde and 20  SSC for 30min at 608C. The
reaction was then loaded onto a nitrocellulose sheet in the
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was removed, air-dried and crosslinked in a Stratalinker at
200J for 9min. The nitrocellulose was prehybridized at
688C for 30min in DIG Easy Hyb (Roche, Germany).
DIG-labeled RNA probes, speciﬁc for either the genome
or the antigenome were produced using DIG Northern
Starter kit (Roche, Germany). Following the addition of
the probes at 100ng probe/ml, the blots were incubated at
688C for 16h. Following the hybridization, the membrane
was immediately submerged in the tray that contained
Low Stringency Buﬀer (2 SSC with 0.1% SDS) at
room temperature for 5min with shaking. Then, the blot
was incubated twice (2 15min, with shaking) in High
Stringency Buﬀer (0.1 SSC with 0.1% SDS) at 688C.
The membrane was then incubated with wash buﬀer for
2min at room temperature with shaking. After the mem-
brane had been blocked with blocking solution for 30min,
it was incubated with the anti-Digoxigenin-AP antibody
solution for 30min and then washed twice with washing
buﬀer (0.1M Maleic acid, 0.15M NaCl; pH 7.5; 0.3%
(v/v) Tween 20). It was then equilibrated for 5min in
20ml detection buﬀer (0.1M Tris–HCl, 0.1M NaCl, pH
9.5). Finally, the chemiluminescent substrate (CDP-Star)
was added to the membrane and the membrane was
exposed to a Kodak ﬁlm.
Expression and purification of recombinant PTB protein
PTB cDNA that was derived from SF268 cellular mRNA
was cloned into PET30a, a prokaryotic expression vector
that contained a histidine tag (Novagen Inc., Madison,
Wisc., USA), via restriction sites EcoR I and Hind III.
After the constructed plasmid (pET30a/PTB) was intro-
duced into a competent cell E. coli BL21 (DE3 pLysS),
His-PTB fusion protein expression was induced with
40mM isopropyl b-D-thiogalactopyranoside (IPTG) at
378C for 2h. The recombinant protein was then puriﬁed
using a HisTrap
TM kit (Pharmacia, NJ, USA). The con-
centration of the protein was measured by Bio-Rad
protein assay (Bio-Rad).
RESULTS
FBP2associates withEV71 5’ UTR
To gain a better understanding of the function of EV71 50
UTR that contains IRES, biontinylated RNA-aﬃnity
chromatography, followed by matrix-assisted laser deso-
rption ionization/time-of-ﬂight mass spectrometry
(MALDI-TOF MS), was performed to isolate and identify
cellular proteins that associate with EV71 50 UTR RNA.
The full-length sequence of EV71 50 UTR that retains full
activity and maintains the correct secondary structure of
IRES was employed. Streptavidin beads were used to cap-
ture biotinylated EV71 50 UTR bound to cellular proteins.
Figure 1A presents the results of a biotinylated RNA-
aﬃnity chromatography assay. Lane 1 presents the con-
trol without any RNA. The patterns of the pull-down
protein bands of the control and SF268 cell lysates that
were incubated with biotin-16-UTP (lane 2) were identical.
When the cell lysates were reacted with biotinylated EV71
50 UTR, at least 16 bands with distinct sizes (lane 4) were
present in the SF268 cells, suggesting that these proteins
may be associated speciﬁcally with the EV71 50 UTR. In
the reactions of cell extracts with non-biotinylated EV71 50
UTR, the patterns of the protein bands (lane 3) were
identical to those of the controls.
The protein bands that were speciﬁcally associated with
biotinylated EV71 50 UTR RNA (lane 4) in Figure 1A
were then extracted, digested with trypsin, and subjected
to MALDI-TOF MS analysis. Table 1 presents these pro-
teins with their accession numbers obtained from the pro-
tein database. Sixteen bands, presenting 12 proteins, were
identiﬁed. They comprised three known ITAFs that inter-
acted with the IRES of picornavirus. They were polypyr-
imidine tract-binding protein (PTB, bands 11-1 and 11-2),
poly(C) binding protein 2 (PCBP2, bands 12 and 13) and
poly(C) binding protein 1 (PCBP1, band 14).
One novel protein far upstream element binding protein
2 (FBP2, band 5) was chosen and its functions on EV71 50
UTR were investigated. To conﬁrm the interaction
between the EV71 50 UTR and FBP2, the RNA-protein
pull down assay was performed as described, and diﬀerent
amounts of non-biotinylated EV71 50 UTR or yeast tRNA
was added for competition assay. As revealed by
Figure 1B, this interaction was out-competed by non-bio-
tinylated EV71 50 UTR (lanes 3, 4 and 5) but not by yeast
tRNA (lanes 8, 9 and 10), demonstrating that FBP2 does
not interact non-speciﬁcally with any RNA sequence.
The above experiments were conducted in SF268 cells.
To know whether the interactions also occurred in other
cells, RNA-protein pull down assay was performed in var-
ious cell extracts. As shown in Figure 1C, the association
of FBP2 with biotinylated EV71 50 UTR occurred not
only in neural cells lines, SK-N-MC (lane 5) and SF268
cells (lane 10), but also in the non-neural cell line, RD cells
(lane 15). The association of FBP2 with EV71 50 UTR is
likely to be a common interaction amongst diﬀerent
cell lines.
Interaction regionsin viral RNA and inFBP2 protein
EV71 50 UTR contains cloverleaf and IRES structures,
verifying and elucidating in greater detail the interaction
between EV71 50 UTR and FBP2, enabling the binding
regions in both viral RNA and FBP2 protein to be further
mapped. Figure 2A presents the potential secondary struc-
ture of EV71 50 UTR as predicted by M-FOLD. Various
truncated forms of viral RNAs, as displayed in Figure 2B,
were synthesized by in vitro transcription and labeled
with biotin. The aforementioned RNA protein pull-
down assay was performed, and the streptavidin beads
were used to capture the biotinylated viral RNA and its
associated cellular proteins from SF268 cells. Western blot
was then conducted to measure the interactions of FBP2.
As presented in Figure 2B, biotinylated probes 1–167
(lane 4), 91–228 (lane 6), 91–636 (lane 12), 91–745 (lane
14), 453–636 (lane 20), 453–745 (lane 22) and 566–745
(lane 24) pulled down FBP2 from SF268 cell lysates,
while the other probes did not. The results suggest that
FBP2 may interact with the nt 1–167 (stem-loop I-II),
91–228 (stem-loop II-III) and 566–745 (stem-loop VI
and spaer region) regions in EV71 50 UTR.
50 Nucleic Acids Research, 2009, Vol. 37,No. 1FBP2 contains a proline/glycine-rich N-terminus with a
nuclear localization signal, a central region with four
KH-type RNA-binding domains and an unusual C ter-
minus rich in glutamine with four degenerate copies of
the repeat DYTKAWEEYYKK. An attempt was made
to identify the domains within FBP2 that are involved in
the interaction with EV71 50 UTR. Diﬀerent truncated
forms of DNA constructs were generated to express
Figure 1. Identiﬁcation of interaction of FBP2 with enterovirus 71 50 untranslated region (EV71 50 UTR). (A) Identiﬁcation of cellular proteins
associated with EV71 50 UTR. RNA-protein pull-down experiments were performed as described in Materials and methods section. EV71 50 UTR
was labeled with biotin and incubated with SF268 cell lysate (200mg) for 15min at 308C. Streptavidin was then used to pull down biotin-labeled
RNA (EV71 50 UTR) and its associated cellular proteins (lane 4). After they had been washed and dissociated from RNA, the eluted proteins were
boiled and subjected to SDS–PAGE (8–16% gradient gel). Silver staining was applied for visualization. In the negative controls, no RNA was added
to the reaction for lane 1; biotin-16-UTP was added to the reaction for lane 2; non-biotinylated RNA was added to the reaction for lane 3. A
comparison with the control lanes 1–3 revealed that some protein bands appeared only in lane 4. Those bands were excised, digested in gel, and
analyzed by MALDI-TOF. (B) Speciﬁc association of FBP2 with EV71 50 UTR was conﬁrmed by western blot and competition assay. The pull-
down assay that was displayed in Figure 1A was performed here. The eluted proteins were also subjected to SDS–PAGE (12%). Antibody against
FBP2 was utilized in the western blot analysis. Various amounts of unlabeled RNA were added to compete with biotin-labeled EV71 50 UTR in
interacting with FBP2. Lanes 1 and 6 contained cell lysate (200mg) only. Unlabeled EV71 50 UTR was used in the competition assay (lanes 3–5), and
unlableled yeast tRNA was utilized (lanes 8–10). (C) EV71 50 UTR associates with FBP2 in the various cell lines. The 100% inputs of diﬀerent cell
extracts only are shown in lanes 1, 6 and 11. SK-N-MC, SF268 and RD cell extracts were incubated in the absence of RNA (lanes 2, 7 and 12) or in
the presence of biotin-16-UTP (lanes 3, 8 and 13), non-biotinylated full-length EV71 50 UTR (lanes 4, 9 and 14) or biotinylated full-length EV71 50
UTR (lanes 5, 10 and 15). After the beads were washed, bound proteins were resolved using 12% SDS–PAGE. FBP2 protein was visualized by
immunoblot analysis with anti-FBP2 proteins antibody.
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to interact with EV71 50 UTR was tested by RNA-protein
pull down assay. These plasmids were transfected indivi-
dually into RD cells and the cell lysates were utilized in
RNA-protein pull down experiments. The expressions of
FBP2 (lane 1) and the truncated forms (lanes 4, 7, 10
and 13) were visualized by western blot using anti-ﬂag
antibody (Figure 3B). Streptavidin beads captured bioti-
nylated EV71 50 UTR and its associated full-length FBP2,
as well as two truncated forms, FBP2-KH1-4 and FBP2-
KH2-4, but not FBP2-KH1-3 and FBP2-KH3-4. These
results suggest that FBP2 may interact with EV71 50
UTR through a region that contains at least KH2 and
KH4 RNA-binding domains.
Figure 2. Interaction regions in EV71 50 UTR for FBP2. (A) Predicted RNA secondary structure for 50 UTR. M-FOLD software was utilized to
predict the RNA secondary structure. The ﬁrst and the last nucleotides in each stem-loop are numbered as indicated. (B) Map of regions of
interaction in RNA. Various truncated forms of RNA, as indicated, were transcribed in vitro and biotinylated. SF268 cell lysates were incubated
with those biotin-labeled RNAs (lanes 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22 and 24). Non-biotinylated RNA probes were as controls (lanes 1, 3, 5, 7, 9,
11, 13, 15, 17, 19, 21 and 23). After being pulled down by streptavidin beads, the protein complex was dissolved in the SDS–PAGE as described
above. Western blot was then applied to detect FBP2 in the pull-down complex.
Table 1. MALDI-TOF results for cellular proteins associated with EV71 50 UTR
Number NCBI Match Sequence
Coverage
(%)
Mass
(Da)
1 Pro alpha (I) collagen 76045 13 139571
2 Lrp protein S57723 15 100135
3 PTB-associated splicing factor, long form A46302 24 76216
4 Keratin — — —
5 Fuse binding protein 2 Q92945 46 68735
6 glycyl-tRNA synthetase P41250 27 83828
7 glycyl-tRNA synthetase P41250 23 83828
8 FUSE binding protein Q12828 37 67690
9 Keratin — — —
10 Heterogeneous nuclear ribonucleoprotein K P61978 35 50996
11-1 Polypyrimidine tract-binding protein PTB-1 Q9BUQ0 35 59767
11-2 Polypyrimidine tract-binding protein PTB-2 S23016 35 59172
12 poly(rC) binding protein 2 Q6IPF4 40 38955
13 poly(rC) binding protein 2 Q6IPF4 41 38955
14 poly(rC) binding protein 1 S58529 21 37987
15 Keratin — — —
16 Heterogeneous nuclear ribonucleoprotein A1 ROA1_HUMAN 47 38805
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compartments
FBP2 is localized in the nucleus, while EV71 replication
occurs in the cytoplasm. How FBP2 in the nucleus associ-
ates with EV71 50 UTR is unclear. To characterize further
the cellular localization of FBP2 in EV71-infected cells,
their subcellular localization after EV71 infection was
compared with that after mock infection by ﬂuorescence
microscopy. For this purpose, DNA constructs were gen-
erated to express FBP2 fused with the ﬂag. These con-
structs were transfected into RD cells for 2 days and
then the transfected cells were infected by EV71at 40
MOI; the subcellular distribution of the fusion proteins
was analyzed by ﬂuorescence confocal microscopy at 6-h
post-infection. In the absence of EV71 infection, FBP2
protein is mainly localized in the nucleus of the cells
(Figure 4A-4). However, EV71 infection redistributes
FBP2 to the cytoplasm (Figure 4A-9). Staining with anti-
body against viral 3A protein identiﬁed the EV71-infected
cells. Hoechst 33258 was the dye speciﬁc for the nucleus.
The data indicate that FBP2 is being relocalized from the
nucleus to the cytoplasm or retained in the cytoplasm
during EV71 infection.
FBP2associates withEV71 5’UTR in EV71infection
FBP2 was determined to redistribute to the cytoplasm
upon EV71 infection, and then whether the FBP2 associ-
ates with EV71 50 UTR in EV71 infected-cells was exam-
ined. FBP2/FLAG was overexpressed in RD cells, which
were then challenged by EV71at 40 MOI. After 6, 7 and
8h EV71 post-infection, the cells were lyzed and the RNA-
protein complexes were immunoprecipitated by antibody
speciﬁc to ﬂag that fused with FBP2 or HA (as a negative
control). RNA was isolated from these immunoprecipi-
tates and then subjected to the RT-PCR reaction
using with primers speciﬁc to either EV71 50 UTR or ribo-
somal protein S16 (RPS16, as a control). At 6, 7 and
Figure 3. Interaction domains in FBP2 protein for EV71 50 UTR.
(A) Schematic diagram of FBP2 and various truncated mutants. The
KH domains are indicated by black boxes. Four truncated forms,
FBP2-KH1-4, FBP2-KH1-3, FBP2-KH2-4 and FBP2-KH3-4 were gener-
ated and fused with Flag at their N terminals. (B) Expressions of
truncated forms of FBP2 in RD cells and mapping interaction regions
in FBP2. Plasmids that carried wild-type (lane 1) or various truncated
forms of FBP2 (lanes 4, 7, 10 and 13) were transfected into RD cells.
Western blot using anti-Flag antibody was employed to examine pro-
tein expression. Cell extracts from transfected cells were collected 48h
post-transfection and then incubated with biotinylated RNA (EV71 50
UTR). Streptavidin beads were used in the pull-down assay and the
complex was dissolved for SDS–PAGE analysis. The amount of ‘input’
was exactly the same (100%) as the total amount of material used in
the binding reaction.
Figure 4. FBP2 localized to cytoplasm and associated with EV71 50 UTR in EV71-infected cells. (A) Eﬀect of EV71 infection on FBP2 localization.
RD cells were transfected with pFlag-CMV2-FBP2. After 2 days, transfected cells were mock-infected or infected with EV71at 40 MOI for 6h and
then ﬁxed and stained with antibodies directed against Flag and viral protein 3A. Panels 1 and 6 show cells examined with a Rhodamin ﬁlter; panels
2 and 7 show cells examined with a FITC ﬁlter; panels 3 and 8 present Hoechst 33258 staining of the same ﬁeld with a 40,6 0-diamidino-
2-phenylindole (DAPI) ﬁlter; panels 4 and 9 show merged FITC and Hoechst images and panels 5 and 10 present the phase of the cells.
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dies coprecipitated EV71 50 UTR (Figure 4B, lane 2), but
not the control RNA (RPS16) (Figure 4B, lane 7), con-
ﬁrming that FBP2 associates with EV71 50 UTR in EV71
infected cells. No speciﬁc band that represented EV71 50
UTR or RPS16 was detected when the reaction proceeded
with anti-HA antibody (Figure 4B, lanes 3 and 8) or with-
out antibody (Figure 4B, lanes 4 and 9). H2O as a template
was an RT-PCR negative control (Figure 4B, lanes 5 and
10). The results of Figures 1 and 4B together demonstrate
that FBP2 associates with EV71 50 UTR both in vivo and
in vitro.
Viral protein synthesis was increased upon knockdown
of FBP2and decreased uponover-expression ofFBP2
FBP2 was mapped to interact within the regions of IRES
which is reported to participate in viral protein transla-
tion. This investigation further examined the synthesis of
viral protein in knocked-down FBP2 or over-expressed
FBP2. The RNA interference (RNAi) method was applied
to investigate the dependency of EV71 translation on
FBP2 in vivo. To examine the eﬀect of FBP2 knockdown
on EV71 translation, RD cells were transfected with
siRNA (NC as negative control or siRNA against
FBP2) and then infected with EV71at 40 MOI. The cells
were pulse-labeled with [
35S] methionine at various times
post-infection, and extracts were analyzed by SDS–12%
PAGE. Infection with EV71 inhibited the synthesis of host
cell protein (Figure 5A and C), as expected. The results
showed that viral protein synthesis in FBP2-depleted cells
exceeded that in NC siRNA-treated cells (Figure 5A);
whereas viral protein synthesis in FBP2-overexpressed
cells was less than that of control (transfected with
FLAG vector only) cells (Figure 5C). Figure 5B displays
knockdown eﬃciency of FBP2 and Figure 5D exhibits the
over-expression of FBP2. The integrity of cellular protein,
eIF4G that has been reportedly cleaved by viral 2A pro-
tease shortly after viral infection, was also monitored. This
result reveals that FBP2 may participate in viral transla-
tion as a negative modulator.
FBP2 negatively regulates IRES-dependent translation
of EV71
During EV71 infection, the IRES-mediated initiation of
translation allows viral RNA translation. Whether the
knockdown or over-expression of FBP2 has any eﬀect
on EV71 IRES activity was further examined. A dicistro-
nic reporter plasmid was used to evaluate EV71 IRES
activity (Figure 6A); translation of the ﬁrst cistronic
(Renilla luciferase, RLuc) is cap-dependent, whereas the
translation of second cistronic (Fireﬂy luciferase, FLuc) is
dependent on EV71 IRES activity. Calculating the ratio of
FLuc expression to RLuc expression yields the relative
IRES activity. First, the siRNA duplex—either NC
siRNA or siRNA against FBP2—was transfected to RD
cells, and then the siRNA duplex and the dicistronic plas-
mid were co-transfected into RD cells after 72h post-
transfection. Cell lysates were collected and analyzed
to determine RLuc and FLuc activity after 48h post-
transfection. Knockdown of endogenous FBP2 protein
increases EV71 IRES activity to 135% (P<0.001) of
that of the NC control (Figure 6A, left). The lower
panel of 6A presents the knockdown eﬃciency of FBP2.
Moreover, RD cells were transiently transfected with a
FLAG-tagged FBP2 or FLAG-expressing plasmid, and
the dicistronic plasmid was then transfected into cells
after 48h post-transfection. Cell lyastes were also collected
and analyzed to determine RLuc and FLuc activity after
48h post-transfection. Over-expression of FBP2/FLAG
reduced the EV71 IRES activity to 74% (P<0.05)
(Figure 6A, right). The lower panel of Figure 6A shows
the over-expression eﬃciency of FBP2.
Figure 4. Continued.
(B) EV71 50 UTR RNA was pulled down with FBP2 from EV71-
infected cell extracts. RD cells were transfected with pFlag-CMV2-
FBP2. After 2 days, transfected cells were infected by EV71at 40
MOI. The cell extract was collected 6h post-infection. Anti-Flag anti-
body was used in the immunoprecipitation assay. Following washing
and dissociation, the RNA was extracted and subjected to the RT-PCR
reaction using primers that were speciﬁc to either EV71 50 UTR or
ribosomal protein S16 (RPS16). Cell lysate without immunoprecipita-
tion was used for RNA extraction (lanes 1 and 6) as an RT-PCR
control. Anti-Flag antibody was incubated with 200mg infected cell
lysate and then underwent RNA extraction and RT-PCR analysis
(lanes 2 and 7). The same reaction with anti-HA antibody or without
antibody was performed used as a negative control (lanes 3, 4, 8 and 9).
H2O as a template was an RT-PCR negative control (lanes 5 and 10).
FBP2 protein binds to the EV71 50 UTR RNA but not to the control
RNA (RPS16).
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was performed. Figure 6B indicates that EV71 IRES activ-
ity is increased to 111% (P<0.05) in FBP2-knockdown
cells and reduced to 90% (P<0.001) in FBP2-overe-
pressed cells. The FLuc/RLuc ratio following DNA trans-
fection may be related to a nuclear event, such as the use
of a cryptic promoter or the splice site in the IRES
sequence. Accordingly, monocistronic mRNAs that con-
tained the EV71 50 UTR were alternatively transfected
into RD cells, and the FLuc activity was measured after
RD cells were transfected by FBP2 siRNA (knock-down)
or FBP2/FLAG (over-expression). The knockdown of
endogenous FBP2 protein increased EV71 IRES activity
to 132% (P<0.05) of that of the NC control (Figure 6C,
left). The lower panel of Figure 6C displays the knock-
down eﬃciency of FBP2. RD cells were transiently trans-
fected with a FLAG-tagged FBP2 or FLAG-expressing
plasmid, and then the monocistronic mRNA was trans-
fected into cells after 48-h post-transfection. Cell lyastes
were also collected and analyzed to determine FLuc activ-
ity after 6h post-transfection. The over-expression of
FBP2/FLAG reduced EV71 IRES activity to 57%
(P<0.05) (Figure 6C, right). These results together indi-
cate that FBP2 may act as a negative regulator of EV71
IRES function.
Mechanism of negativeregulation by FBP2
Two hypotheses seek to explain how FBP2 serves as a
negative regulator of EV71 IRES. First, FBP2 is an
important adenosine-uridine element binding protein
(ARE-BP) that is known to inﬂuence RNA stability. In
this work, the viral RNA integrity was further investigated
in FBP2 knocked-down cells. The right panel of Figure 7A
reveals that FBP2 was knocked down by its speciﬁc
siRNA. 40 MOI of EV71 was used to infect cells and
viral RNAs were extracted at various times post-infection.
Slot-blot assay using a speciﬁc RNA probe against either
positive or negative sense EV71 viral RNA was employed
to monitor viral RNA synthesis. The results in Figure 7A
indicate that neither positive nor negative stranded EV71
RNA in FBP2 siRNA-treated cells diﬀered from that in
NC siRNA-treated cells.
Another hypothesis is that FBP2 competes with other
positive ITAFs to bind with speciﬁc EV71 IRES and
thereby negatively regulate IRES activity. In vitro compe-
tition binding assay was performed. Various amounts of
recombinant PTB protein, a positive ITAF of picorna-
virus, were added to the in vitro binding assay and the
results show that FBP2 outcompeted PTB for IRES bind-
ing (Figure 7B). Taken together, these results support the
second hypothesis—that FBP2 may compete with EV71
positive ITAFs, so that FBP2 acts as negative regulator.
DISCUSSION
An internal ribosomal entry site (IRES) that directs the
initiation of viral protein translation is a potential drug
target for enterovirus 71 (EV71). This investigation iden-
tiﬁed the trans-acting factors associated with EV71 50
UTR to elucidate the mechanism of the initiation of
Figure 5. FBP2 regulates EV71 viral protein synthesis. (A) Transfection of siRNA [negative control siRNA (NC siRNA), or siRNA against FBP2
(FBP2 siRNA)] in RD cells was performed in 12-well plates. Following transfection, cells were infected with EV71 or mock-infected, and protein
synthesis was examined by pulse-labeling at various times, as described in Materials and methods section. (B) Western blot analysis of FBP2 protein.
(C) Transfection of FLAG or FBP2/FLAG plasmid DNA in RD cells was performed in 12-well plates. Following transfection, cells were infected
with EV71 or mock-infected, and protein synthesis was examined by pulse-labeling at various times, as described in Materials and methods section.
(D) Western blot analysis of FBP2/FLAG protein.
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employed experimental strategy involved either UV
cross-linking or electrophoretic mobility-shift assays to
identify proteins that interact with picornavirus 50 UTR.
However, this work utilizes a biotinylated RNA-protein
pull-down assay, combined with MALDI-TOF analysis,
to provide a global view of cellular proteins that associate
with EV71 50 UTR.
IRES-speciﬁc trans-acting factors (ITAFs) that are
involved in the functionality of the EV71 IRES are
sought and far upstream element binding 2 (FBP2) is iden-
tiﬁed as a novel EV71 IRES ITAFs. FBP2 is also known
as KH-type splicing regulatory protein (KSRP). It is ori-
ginally identiﬁed as a component of a protein complex
that assembles on an intronic c-src neuronal-speciﬁc spli-
cing enhancer, is an important adenosine-uridine element
binding protein (ARE-BP) that is known to interact with
several AREs (22,23).
This study is ﬁrst to report that FBP2 binds to the
highly structured EV71 50 UTR. This fact is demonstrated
by RNA aﬃnity capture experiments. It demonstrates that
the binding of FBP2 to EV71 50 UTR is speciﬁc. Its bind-
ing to biotinylated EV71 50 UTR is not competitively
eliminated by non-speciﬁc RNA, such as yeast tRNA
(Figure 1B, lanes 8–10), but is competitively eliminated
by cold non-biotinylated EV71 50 UTR in a concentra-
tion-dependent manner (Figure 1B, lanes 3–5). Since
FBP2 proteins mostly accumulate in the nuclear compart-
ment (24), an important question is how a nucleus-loca-
lized host protein interacts with EV71 RNA in the
cytoplasm and modulates viral replication. Immunoﬂuor-
escence experiments have indicated that a signiﬁcant por-
tion of FBP2 is present in the cytoplasm after EV71
infection (Figure 4A), where it can interact with EV71
RNA. Co-immunoprecipitation assay is also employed
to demonstrate that FBP2 associates with EV71 50 UTR
in EV71-infected cells (Figure 4B).
A single-cycle virus replication assay was conducted in
FBP2-knockdown and FBP2-overexpressed cells. Viral
yields decreased slightly by less than order of magnitude
in FBP2-overexpressed cells, but did not visibly observa-
bly diﬀer in FBP2-knockdown cells. FBP2 seemingly mod-
ulates viral protein synthesis (Figure 5), but whether FBP2
inﬂuences any other cellular process during EV71 infec-
tion is unclear. The eﬀect of FBP2 on cellular machinery
Figure 6. Eﬀects of down-regulation and up-regulation of FBP2 on
EV71 IRES activity. (A) Schematic diagram of dicistronic reporter
plasmids pRHF and pRHF–EV71-50UTR. Plasmid expresses dicistro-
nic mRNA, consisting of the Renilla luciferase (RLuc) gene at the ﬁrst
cistron and the EV71-50 UTR and the Fireﬂy luciferase (FLuc) gene at
the second cistron (CMV, cytomegalovirus). A hairpin (H) is inserted
downstream of the ﬁrst cistron to prevent ribosome read-through. RD
cells were ﬁrstly transfected with either FBP2 siRNA or pFBP2/FLAG.
After 3 days, dicistronic construct pRHF or pRHF–EV71-50UTR and
siRNA duplexes were cotransfected into RD cells with siRNA duplex.
At 48-h post-cotransfection, the Renilla luciferase (RLuc) and Fireﬂy
luciferase (FLuc) activity in cell lysates were analyzed. The bars in the
histogram represent FLuc/RLuc activity percentages. Experiments were
performed in triplicate to obtain the bar graph. Western blotting was
utilized analyze the expression levels of FBP2, FBP2/FLAG and actin.
(B) Schematic diagram of capped dicistronic mRNAs containing a
poly(A) tail. RD cells transfected with either FBP2 siRNA or FBP2/
FLAG were grown for 3 days and then transfected with RHF or RHF-
EV71-50 UTR. After 6-h post-transfection, cells were harvested, lysed
and western blotted for FBP2, FBP2/FLAG and actin. An aliquot of
the lysate was assayed for Renilla luciferase and Fireﬂy luciferase
(FLuc) activity. (C) Schematic diagram of monocistronic reporter plas-
mids EV71 50 UTR-FLuc. RD cells transfected with either FBP2
siRNA or FBP2/FLAG were grown for 3 days and then transfected
with EV71 50 UTR-FLuc mRNA. After 6-h post-transfection, cells
were harvested, lysed and western blotted for FBP2, FBP2/FLAG
and actin. An aliquot of the lysate was assayed for Fireﬂy luciferase
(FLuc) activity. (
 P<0.05 and
   P<0.001, Student’s two-tailed
unpaired t-test).
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then exhibited no observable diﬀerence in viral titer when
a single-cycle virus was replicated in FBP2-knockdown
cells in which viral yields were expected to be increased.
The viral components i.e. viral RNA and viral proteins
are made in great excess under normal condition in
infected cells. Therefore several fold ﬂuctuation in the
amounts of viral proteins would not be expected to reﬂect
in virus yield. As the amounts of viral proteins are surplus
in untreated cells, the ‘extra’ amounts of viral proteins
( 2-fold) made in FBP 2-depleted cells would not drama-
tically increase the virus yield. Similarly, the decreased
synthesis of viral proteins ( 2-fold) resulted from over-
expression of FBP2 would not signiﬁcantly decrease the
virus yield. We therefore would like to emphasize the
eﬀect of FBP 2 is mainly on the viral protein synthesis,
i.e. the IRES-dependent translation. The growth rate of
EV71 was found slower than that of other enteroviruses
(PV, CB3, etc). We have performed ‘one-step’ growth rate
analysis and noticed that the viral titer usually peaks and
reaches plateau at 12–15h (data not shown). We also per-
formed extensive time course experiments to monitor the
viral translation, and found little viral protein synthesis at
early time points by metabolic radiolabeling experiment.
As a result the eﬀect of FBP2 on viral protein synthesis
was hardly evaluated prior to 6-h post-infection
(Figure 5).
Many other proteins that are primarily localized in the
nucleus also interact with picornaviral RNA in the cyto-
plasm. Various nuclear localization cellular factors, such
as PTB (25), hnRNP C (26), hnRNP K (27), hnRNP A1
(28) and nuclear factors (NF45) (29), interact with picor-
naviral RNA and aﬀect picornaviral replication and/or
translation. The interaction between the nucleus-localized
host cellular factors and EV71 RNA provides two impor-
tant pieces of information for viral-host interactions on
EV71 infection. First, EV71 infection may inﬂuence the
cellular distribution of numerous host proteins, such as
hnRNP A1, hnRNP K and hnRNP C (27,30) and the
nuclear factors (NF45) (29). Second, some of these host
proteins, such as PTB (25), hnRNP C (26) and the nuclear
factors (NF45) (29), may have important, active functions
in the viral life cycle.
Why did FBP2 relocalize to cytoplasm—because EV71
RNA simply tethers FBP2 in the cytoplasm or because
EV71 infection inﬂuences the nuclear-cytoplasmic trans-
port of FBP2? The localization of FBP2 in EV71 IRES
reporter construct-transfected cells was examined. FBP2
remained localized in the nuclei of transfected cells
(Figure S1 in the Supplementary Data). The results sug-
gest that EV71 infection but not IRES alone caused the
relocalization of FBP2, which also highlights the modest
eﬀect of FBP2 knockdown on the EV71 IRES reporter
constructs (Figure 6). Therefore, EV71 IRES activity
was measured again with co-infection with EV71.
Figure S2 in the Supplementary Data presents the results.
After 2h post-infection, monocistronic mRNA that con-
tains EV71 IRES and FLuc as a reporter was transfected
into cells. Cell lysates were collected and analyzed to
determine FLuc activity after 4h post-transfection. The
results indicate that EV71 infection increased the eﬀect
of FBP2 on EV71 IRES activity by a factor of  1.2
times over that of mock-infection.
Two speculated hypotheses seek to explain how FBP2
serves as a negative regulator of EV71 IRES. First, FBP2
is an important ARE-BP that is known to interact with
many AREs. The central part of the protein is organized
in four K-homology domains. The KH4 domain of FBP2
is essential for mRNA decay and ARE recognition, and its
deletion results in the complete loss of these activities
(31,32). FBP2 interacts with the AU-rich elements that
destabilize fos mRNA and with the human exosome com-
plex in vitro. Depletion/addback experiments in a cyto-
plasmic in vitro degradation system support a role for
the protein involvement in targeting mRNAs for degrada-
tion (23). The interaction between FBP2 and EV71 50
UTR was veriﬁed by mapping the interaction regions to
nt 1–167, 91–228 and 566–745 in EV71 50 UTR and
KH2 and KH4 domains in FBP2 (Figures 2B and 3B).
FBP2 may inhibit EV71 IRES because the binding of
Figure 7. Mechanism of negative regulation by FBP2. (A) Viral RNA
synthesis was not aﬀected in FBP2 knock-down cells. After RD cells
had been transfected with FBP2 and NC siRNA for 48-h, the cells were
reseeded into plates. 24-h thereafter, the cells were infected with EV71
(4643/TW/1998) at 40 MOI and RNA was extracted at various times
post-infection. RNA was loaded onto a nitrocellulose sheet in the slot-
blot manifold. After washing, it was air-dried and crosslinked, and the
nitrocellulose was prehybridized. DIG-labeled RNA probes, speciﬁc for
either the genome or the antigenome were added and incubated.
Following washing and blocking, the blots were incubated with chemi-
luminescent substrate for visualization. (B) FBP2 was outcompeted by
PTB recombinant protein for IRES binding. The pull-down assay that
was displayed in Figure 1A was performed here. The eluted proteins
were subjected to SDS–PAGE (12%). Antibodies against FBP2 and
PTB were utilized in western blot analysis. Various amounts of PTB
recombinant protein were added to compete with FBP2 in interacting
with biotin-labeled EV71 50 UTR. In the negative control, non-
biotinylated RNA was added to the reaction in lane 1. PTB competitor
was used in the competition assay (lanes 3–6).
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and therefore degrades the viral RNA. Second, some cel-
lular proteins identiﬁed from MALDI-TOF in Table 1
were mapped as having the binding sites in EV71 50
UTR that overlap with that of FBP2. Such proteins are
PTB, hnRNP A1 and FBP (data not shown). This ﬁnding
raises one possibility that FBP2 may compete with other
ITAFs to bind with speciﬁc EV71 IRES and thereby reg-
ulate IRES activity in a negative manner. An in vitro com-
petition binding assay was performed and the results in
Figure 7B reveal that FBP2 outcompeted the binding of
PTB. PTB has been demonstrated to be a positive ITAF
for other picornaviruses (20,33). The result suggests that
FBP2 may compete with other ITAFs to act as a negative
regulator of EV71 IRES.
The FLuc/RLuc ratio following DNA transfection may
also be related to a nuclear event, such as the use of a
cryptic promoter or the use of a splicing site in the
IRES sequence. Accordingly, monocistronic mRNA was
utilized to measure EV71 IRES activity. The results of
EV71 IRES activity were consistent with that of a dicis-
tronic construct. All of the results reveal that the knocking
down of FBP2 expression increase EV71 IRES activity,
while the up-regulation of FBP2 expression reduced
EV71 IRES activity (Figure 6A, B and C). The sequence
of the construct was examined and no splicing site was
present within EV71 IRES. RT-PCR was also performed
to conﬁrm the absence of a splicing product of EV71 IRES
RNA (Figure S3).
To our knowledge, this investigation is the ﬁrst to
describe on the molecular level negative regulation by
FBP2 of EV71 translation. These studies help not only
to understand the function of IRES but also further inves-
tigations of the mechanism by which cellular proteins are
involved in EV71 infection.
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